Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic theoretical model without primary data or systematic search
PubMed 25713056 · doi:10.1096/fj.14-268342
What was done
The authors synthesized existing literature to propose a mechanistic model linking vitamin D and marine omega-3 fatty acids (EPA and DHA) to brain serotonin synthesis, release, and receptor signaling, and discussed its potential relevance to ADHD, bipolar disorder, schizophrenia, and impulsive behavior.
What was found
The abstract reports no primary experimental trial results or quantitative clinical data, noting only that inadequate vitamin D levels affect approximately 70% of the population. The authors propose that vitamin D transcriptionally activates tryptophan hydroxylase 2 to synthesize serotonin, EPA enhances presynaptic serotonin release by reducing E2-series prostaglandins, and DHA modulates postsynaptic serotonin receptor function by increasing membrane fluidity.
Why it matters
It outlines a biological framework explaining how common nutritional deficiencies in vitamin D and omega-3 fatty acids could interact with developmental and genetic factors to impair central serotonergic signaling in psychiatric conditions.
Limits
This is a theoretical narrative review proposing biological hypotheses rather than an empirical study or systematic review. The abstract provides no primary human clinical trials, no testing of the proposed causal pathways, and no quantitative outcome measures.
Cited by
- supports DHA deficiency causes structural impairment of neuronal serotonin and dopamine receptors, reducing neurotransmitter binding.